• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely.

作者信息

Watson Timothy, Kakar Puneet, Lip Gregory Y H

出版信息

Int J Clin Pract. 2007 Jan;61(1):6-9. doi: 10.1111/j.1742-1241.2006.01226.x.

DOI:10.1111/j.1742-1241.2006.01226.x
PMID:17229172
Abstract
摘要

相似文献

1
Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely.心房颤动中的卒中风险分层：需要更仔细研究的内容。
Int J Clin Pract. 2007 Jan;61(1):6-9. doi: 10.1111/j.1742-1241.2006.01226.x.
2
Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.心房颤动的危险因素及卒中风险分层：局限性与新机遇
Am Heart J. 2008 Jul;156(1):1-3. doi: 10.1016/j.ahj.2008.02.020. Epub 2008 May 5.
3
[Thromboembolic risk in atrial fibrillation: new clinical perspectives].[心房颤动中的血栓栓塞风险：新的临床视角]
G Ital Cardiol (Rome). 2008 Oct;9(10 Suppl 1):22S-26S.
4
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.正方观点：“华法林应该是老年房颤患者血栓预防的首选药物”。为什么华法林确实应该成为老年房颤患者预防中风的首选药物。
Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344.
5
Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.应对老年人房颤：卒中风险分层与新型抗栓治疗
Geriatrics. 2007 Mar;62(3):22-7.
6
Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.阵发性心房颤动、中风风险与血栓预防
Thromb Haemost. 2008 Jul;100(1):11-3. doi: 10.1160/TH08-05-0331.
7
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.反对观点：“华法林应是老年房颤患者血栓预防的首选药物”。关于老年房颤患者使用口服抗凝治疗的注意事项。
Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.
8
Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.
Ann Neurol. 2008 Nov;64(5):480-3. doi: 10.1002/ana.21551.
9
Anticoagulation: stroke prevention in patients with atrial fibrillation.抗凝治疗：心房颤动患者的卒中预防
Med Clin North Am. 2008 Jan;92(1):143-59, xi. doi: 10.1016/j.mcna.2007.08.007.
10
Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.植入式心脏复律除颤器和心脏再同步治疗除颤器患者中远程心律监测指导抗凝的多中心随机研究：最初入组队列的原理、设计和临床特征——IMPACT研究
Am Heart J. 2009 Sep;158(3):364-370.e1. doi: 10.1016/j.ahj.2009.07.002.

引用本文的文献

1
Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019.2019年心脏病学抗血小板药物和抗凝剂声明
Arq Bras Cardiol. 2019 Aug 8;113(1):111-134. doi: 10.5935/abc.20190128.